AU2001276898A1 - Synthetic peptide for neurological disorders - Google Patents

Synthetic peptide for neurological disorders

Info

Publication number
AU2001276898A1
AU2001276898A1 AU2001276898A AU7689801A AU2001276898A1 AU 2001276898 A1 AU2001276898 A1 AU 2001276898A1 AU 2001276898 A AU2001276898 A AU 2001276898A AU 7689801 A AU7689801 A AU 7689801A AU 2001276898 A1 AU2001276898 A1 AU 2001276898A1
Authority
AU
Australia
Prior art keywords
synthetic peptide
neurological disorders
neurological
disorders
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276898A
Other languages
English (en)
Inventor
Binie V. Lipps
Frederick W. Lipps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001276898A1 publication Critical patent/AU2001276898A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU2001276898A 2000-07-11 2001-07-11 Synthetic peptide for neurological disorders Abandoned AU2001276898A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61335500A 2000-07-11 2000-07-11
US09/613,355 2000-07-11
PCT/US2001/022051 WO2002003922A2 (fr) 2000-07-11 2001-07-11 Peptide de synthese pour traiter des troubles neurologiques

Publications (1)

Publication Number Publication Date
AU2001276898A1 true AU2001276898A1 (en) 2002-01-21

Family

ID=24456992

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276898A Abandoned AU2001276898A1 (en) 2000-07-11 2001-07-11 Synthetic peptide for neurological disorders

Country Status (5)

Country Link
US (1) US7264808B2 (fr)
EP (1) EP1299724B1 (fr)
AU (1) AU2001276898A1 (fr)
DE (1) DE60124915T2 (fr)
WO (1) WO2002003922A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072744A1 (en) * 2002-09-12 2004-04-15 Lipps Binie V. Synthetic peptide as treatment for down's syndrome and schizophrenia
ATE504334T1 (de) 2005-11-03 2011-04-15 Unilever Nv Haarbehandlungszusammensetzungen
US9299634B2 (en) * 2006-05-16 2016-03-29 Broadcom Corporation Method and apparatus for cooling semiconductor device hot blocks and large scale integrated circuit (IC) using integrated interposer for IC packages
US7259237B1 (en) * 2006-12-29 2007-08-21 Miller Kent D Pan-antiviral peptides
US9220743B2 (en) 2010-01-22 2015-12-29 Nuovo Biologics, Llc Pan-antiviral peptides for protein kinase inhibition
US9078878B2 (en) 2010-12-01 2015-07-14 Alderbio Holdings Llc Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
JP6190723B2 (ja) 2010-12-01 2017-08-30 アルダーバイオ ホールディングス エルエルシー 抗ngf組成物およびその使用
US9067988B2 (en) 2010-12-01 2015-06-30 Alderbio Holdings Llc Methods of preventing or treating pain using anti-NGF antibodies
US9539324B2 (en) 2010-12-01 2017-01-10 Alderbio Holdings, Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
DE19508672A1 (de) * 1995-03-10 1996-09-12 Boehringer Mannheim Gmbh Neue cyclische Parathormonfragmente, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US6984486B1 (en) * 1999-02-19 2006-01-10 J. David Gladstone Institutes Synthetic peptide of regulatory virus protein R (VPR) of human immunodeficiency virus type 1 (HIV-1) and the utilization thereof

Also Published As

Publication number Publication date
DE60124915D1 (de) 2007-01-11
EP1299724A2 (fr) 2003-04-09
WO2002003922A2 (fr) 2002-01-17
WO2002003922A3 (fr) 2002-09-26
EP1299724A4 (fr) 2005-01-12
US20040077545A1 (en) 2004-04-22
US7264808B2 (en) 2007-09-04
EP1299724B1 (fr) 2006-11-29
DE60124915T2 (de) 2007-11-29

Similar Documents

Publication Publication Date Title
AU2002221074A1 (en) Polyamide
AU3217900A (en) One-piece synthetic undercarriage
AU2001242743A1 (en) Novel phenylalanine derivative
AU2002355513A1 (en) Road stud
AU2002227941A1 (en) Polyamide
AU6632701A (en) Wear having cup units
AU2001276898A1 (en) Synthetic peptide for neurological disorders
AU2002361728A1 (en) Immunocellular receptors related to neurological disorders
AU2001273217A1 (en) Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
AU2001251321A1 (en) Vancomycin analogs
AU2001292241A1 (en) Benzodiazepine derivative
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001238089A1 (en) Particulate distributor
AU3190899A (en) Methods for detecting neurological disorders
AU2579401A (en) Brain protein markers
AU2001245781A1 (en) Cd18-binding antibodies inhibit stenosis-related disorders
AU2002243375A1 (en) Spring
AU2000271137A1 (en) Flame-sprayer for spraying curbs
AU1283801A (en) Neurological plug
AU2001284272A1 (en) Kinase d interacting protein
AUPQ386899A0 (en) Peptide compounds
AU2001234523A1 (en) Methods for detecting neurological disorders
AU2001234148A1 (en) Antioxidants
AU2001269267A1 (en) Kerb
GB9904465D0 (en) Neurological disorders